ahlam1399
07-13-2016, 01:01 PM
AstraZeneca resolves Faslodex patent litigation in U.S.
(Reuters) - British drugmaker AstraZeneca Plc said on Wednesday it has entered into an agreement with Sandoz, the generic pharmaceuticals division of **vartis AG, to resolve Faslodex patent litigation in the U.S.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=cSOEQgbalMM:ghjdjf8vI6o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cSOEQgbalMM:ghjdjf8vI6o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=cSOEQgbalMM:ghjdjf8vI6o:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cSOEQgbalMM:ghjdjf8vI6o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=cSOEQgbalMM:ghjdjf8vI6o:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/cSOEQgbalMM
(Reuters) - British drugmaker AstraZeneca Plc said on Wednesday it has entered into an agreement with Sandoz, the generic pharmaceuticals division of **vartis AG, to resolve Faslodex patent litigation in the U.S.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=cSOEQgbalMM:ghjdjf8vI6o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cSOEQgbalMM:ghjdjf8vI6o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=cSOEQgbalMM:ghjdjf8vI6o:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cSOEQgbalMM:ghjdjf8vI6o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=cSOEQgbalMM:ghjdjf8vI6o:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/cSOEQgbalMM